Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYAN

Cyanotech (CYAN) Stock Price, News & Analysis

Cyanotech logo

About Cyanotech Stock (NASDAQ:CYAN)

Advanced Chart

Key Stats

Today's Range
$0.33
$0.40
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
13,200 shs
Average Volume
3,483 shs
Market Capitalization
$2.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Stock News Headlines

This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this means and how everyday investors like you can position themselves to potentially profit. The timing couldn't be more critical
Q3 2025 Cyanotech Corp Earnings Call
See More Headlines

CYAN Stock Analysis - Frequently Asked Questions

Cyanotech Co. (NASDAQ:CYAN) announced its quarterly earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.16) earnings per share for the quarter. The biotechnology company earned $5.85 million during the quarter. Cyanotech had a negative net margin of 19.50% and a negative trailing twelve-month return on equity of 44.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL).

Company Calendar

Last Earnings
11/12/2024
Today
7/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAN
Employees
95
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.27 million
Pretax Margin
-19.48%

Debt

Sales & Book Value

Annual Sales
$23.07 million
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
0.30

Miscellaneous

Free Float
5,074,000
Market Cap
$2.86 million
Optionable
Not Optionable
Beta
-0.11
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CYAN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners